More News! 13 Feb 2017
To the Rescue: A Final Phase III Success for Post-Operative Nausea
The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after…
Acacia Pharma
- Latest Posts
Best in Biotech 30 Jan 2017
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an exciting entrepreneurial scene at the…
News and Trends 5 Jan 2016
Say Goodbye to Post-Operation Nausea with this Phase III UK Trial Success
An anti-vomiting medication for post-operative patients has smashed its phase III trial in the UK in one of the largest…
News and Trends 26 Oct 2015
Financial Storm approaching? EU Biotechs start postponing their IPOs in London …
Biotech financing beats record over record since beginning of 2014. Financing has never been as high in Europe (though of…
